Drug Type Small molecule drug |
Synonyms Rimiducid (USAN/INN), AP-1903 |
Target |
Action- |
Mechanism FKBP12 (FK506-binding protein 1A ligand) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC78H98N4O20 |
InChIKeyGQLCLPLEEOUJQC-ZTQDTCGGSA-N |
CAS Registry195514-63-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | United States | 01 Apr 2014 | |
Anemia, Diamond-Blackfan | Phase 2 | United States | 01 Apr 2014 | |
Anemia, Sickle Cell | Phase 2 | United States | 01 Apr 2014 | |
Fanconi Anemia | Phase 2 | United States | 01 Apr 2014 | |
Non-Hodgkin Lymphoma | Phase 2 | United States | 01 Apr 2014 | |
Osteopetrosis | Phase 2 | United States | 01 Apr 2014 | |
Primary Immunodeficiency Diseases | Phase 2 | United States | 01 Apr 2014 | |
Thalassemia | Phase 2 | United States | 01 Apr 2014 | |
Graft vs Host Disease | Phase 2 | United States | 27 Dec 2013 | |
Multiple Myeloma | Phase 2 | United States | 27 Dec 2013 |
Phase 1 | Advanced Malignant Solid Neoplasm | Metastatic castration-resistant prostate cancer | Advanced Prostate Carcinoma prostate-specific antigen | - | mzpkodufyo(htodqxkcht) = odgfdxphdr bpacrdsngi (edznfieaib ) View more | Positive | 30 Dec 2024 | ||
Phase 1 | 7 | flvvpjfvqu(uelyxfaaan) = iewzhxfxqk annllnhcpx (yaifedkbeb ) View more | Positive | 21 Feb 2023 | |||
Phase 2 | - | scukppzatr(usmoifcetg) = yecmufbcwf yfdsdhjwdg (iamhwurzsm, 84.8 - 94.6) | Positive | 08 Jul 2019 | |||
Not Applicable | - | - | ptlxdyfzio(ogqvoqagef) = ealegjqnrs ufemhuyakd (dyvmabbxue ) | - | 01 May 2013 |